SCHEMBL426706

SCHEMBL426706

CN(C(=O)n1cnc(-c2ccc(Cl)cc2)c1)c1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 4/20 0.46
FAAH O00519 1/20 0.44
MAP4K4 O95819 1/20 0.41
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
LIPE Q05469 2/20 0.38
ACHE P22303 1/20 0.38
MLNR O43193 1/20 0.38
DHODH Q02127 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ATM Q13315 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
LTC4S Q16873 1/20 0.37
SCN4A P35499 1/20 0.37
PSD A5PKW4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL427152 0.89 FAAH (0.42) GPBAR1FAAHLMNATP53MLNR
SCHEMBL425400 0.87 FAAH (0.54) FAAHMAP4K4LMNALIPEACHE
SCHEMBL425550 0.87 FAAH (0.51) GPBAR1FAAHLMNATP53KDM4E
SCHEMBL425556 0.85 L3MBTL1 (0.43) FAAHLMNATP53LIPEACHE
SCHEMBL427489 0.79 FAAH (0.40) GPBAR1FAAHLMNATP53MLNR
SCHEMBL427476 0.78 FAAH (0.57) FAAHLMNATP53LIPEACHE
SCHEMBL425371 0.77 FAAH (0.60) FAAHLMNATP53LIPEACHE
SCHEMBL427280 0.77 GPBAR1 (0.46) GPBAR1TP53LIPEACHEKMT2A
SCHEMBL426698 0.75 FAAH (0.52) FAAHLMNATP53LIPEACHE
SCHEMBL11287247 0.75 MAP4K4 (0.50) FAAHMAP4K4LMNATP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9353082-B2 Pharmaceutical compounds BIAL—PORTELA & CA, S.A. (PT) 2016-05-31 US disclosed
US-9353082-B2 Pharmaceutical compounds BIAL—PORTELA & CA, S.A. (PT) 2016-05-31 US disclosed
US-20120065191-A1 PHARMACEUTICAL COMPOUNDS BIAL - PORTELA & Cª, S.A. (PT) 2012-03-15 US disclosed
US-20120065191-A1 PHARMACEUTICAL COMPOUNDS BIAL - PORTELA & Cª, S.A. (PT) 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065191-A1 PHARMACEUTICAL COMPOUNDS FAAH, FAAH2, ASAH1 GPBAR1 218/4885FAAH 1/4885MAP4K4 3117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.